United States Regenerative Medicine Products Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Regenerative Medicine Products Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Regenerative Medicine Products Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Regenerative Medicine Products Overall Market Size
2.1 United States Regenerative Medicine Products Market Size: 2021 VS 2027
2.2 United States Regenerative Medicine Products Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Regenerative Medicine Products Sales: 2016-2027
3 Company Landscape
3.1 Top Regenerative Medicine Products Players in United States Market
3.2 Top United States Regenerative Medicine Products Companies Ranked by Revenue
3.3 United States Regenerative Medicine Products Revenue by Companies
3.4 United States Regenerative Medicine Products Sales by Companies
3.5 United States Regenerative Medicine Products Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Regenerative Medicine Products Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Regenerative Medicine Products Product Type
3.8 Tier 1, Tier 2 and Tier 3 Regenerative Medicine Products Players in United States Market
3.8.1 List of Tier 1 Regenerative Medicine Products Companies in United States
3.8.2 List of Tier 2 and Tier 3 Regenerative Medicine Products Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Regenerative Medicine Products Market Size Markets, 2021 & 2027
4.1.2 Cell Therapy
4.1.3 Tissue Engineering
4.1.4 Biomaterial
4.1.5 Others
4.2 By Type - United States Regenerative Medicine Products Revenue & Forecasts
4.2.1 By Type - United States Regenerative Medicine Products Revenue, 2016-2021
4.2.2 By Type - United States Regenerative Medicine Products Revenue, 2022-2027
4.2.3 By Type - United States Regenerative Medicine Products Revenue Market Share, 2016-2027
4.3 By Type - United States Regenerative Medicine Products Sales & Forecasts
4.3.1 By Type - United States Regenerative Medicine Products Sales, 2016-2021
4.3.2 By Type - United States Regenerative Medicine Products Sales, 2022-2027
4.3.3 By Type - United States Regenerative Medicine Products Sales Market Share, 2016-2027
4.4 By Type - United States Regenerative Medicine Products Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Regenerative Medicine Products Market Size, 2021 & 2027
5.1.2 Dermatology
5.1.3 Cardiovascular
5.1.4 CNS
5.1.5 Orthopedic
5.1.6 Others
5.2 By Application - United States Regenerative Medicine Products Revenue & Forecasts
5.2.1 By Application - United States Regenerative Medicine Products Revenue, 2016-2021
5.2.2 By Application - United States Regenerative Medicine Products Revenue, 2022-2027
5.2.3 By Application - United States Regenerative Medicine Products Revenue Market Share, 2016-2027
5.3 By Application - United States Regenerative Medicine Products Sales & Forecasts
5.3.1 By Application - United States Regenerative Medicine Products Sales, 2016-2021
5.3.2 By Application - United States Regenerative Medicine Products Sales, 2022-2027
5.3.3 By Application - United States Regenerative Medicine Products Sales Market Share, 2016-2027
5.4 By Application - United States Regenerative Medicine Products Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Acelity
6.1.1 Acelity Corporation Information
6.1.2 Acelity Overview
6.1.3 Acelity Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.1.4 Acelity Regenerative Medicine Products Product Description
6.1.5 Acelity Recent Developments
6.2 DePuy Synthes
6.2.1 DePuy Synthes Corporation Information
6.2.2 DePuy Synthes Overview
6.2.3 DePuy Synthes Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.2.4 DePuy Synthes Regenerative Medicine Products Product Description
6.2.5 DePuy Synthes Recent Developments
6.3 Medtronic
6.3.1 Medtronic Corporation Information
6.3.2 Medtronic Overview
6.3.3 Medtronic Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.3.4 Medtronic Regenerative Medicine Products Product Description
6.3.5 Medtronic Recent Developments
6.4 ZimmerBiomet
6.4.1 ZimmerBiomet Corporation Information
6.4.2 ZimmerBiomet Overview
6.4.3 ZimmerBiomet Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.4.4 ZimmerBiomet Regenerative Medicine Products Product Description
6.4.5 ZimmerBiomet Recent Developments
6.5 Stryker
6.5.1 Stryker Corporation Information
6.5.2 Stryker Overview
6.5.3 Stryker Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.5.4 Stryker Regenerative Medicine Products Product Description
6.5.5 Stryker Recent Developments
6.6 MiMedx Group
6.6.1 MiMedx Group Corporation Information
6.6.2 MiMedx Group Overview
6.6.3 MiMedx Group Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.6.4 MiMedx Group Regenerative Medicine Products Product Description
6.6.5 MiMedx Group Recent Developments
6.7 Organogenesis
6.7.1 Organogenesis Corporation Information
6.7.2 Organogenesis Overview
6.7.3 Organogenesis Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.7.4 Organogenesis Regenerative Medicine Products Product Description
6.7.5 Organogenesis Recent Developments
6.8 UniQure
6.8.1 UniQure Corporation Information
6.8.2 UniQure Overview
6.8.3 UniQure Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.8.4 UniQure Regenerative Medicine Products Product Description
6.8.5 UniQure Recent Developments
6.9 Cellular Dynamics International
6.9.1 Cellular Dynamics International Corporation Information
6.9.2 Cellular Dynamics International Overview
6.9.3 Cellular Dynamics International Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.9.4 Cellular Dynamics International Regenerative Medicine Products Product Description
6.9.5 Cellular Dynamics International Recent Developments
6.10 Osiris Therapeutics
6.10.1 Osiris Therapeutics Corporation Information
6.10.2 Osiris Therapeutics Overview
6.10.3 Osiris Therapeutics Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.10.4 Osiris Therapeutics Regenerative Medicine Products Product Description
6.10.5 Osiris Therapeutics Recent Developments
6.11 Vcanbio
6.11.1 Vcanbio Corporation Information
6.11.2 Vcanbio Overview
6.11.3 Vcanbio Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.11.4 Vcanbio Regenerative Medicine Products Product Description
6.11.5 Vcanbio Recent Developments
6.12 Gamida Cell
6.12.1 Gamida Cell Corporation Information
6.12.2 Gamida Cell Overview
6.12.3 Gamida Cell Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.12.4 Gamida Cell Regenerative Medicine Products Product Description
6.12.5 Gamida Cell Recent Developments
6.13 Golden Meditech
6.13.1 Golden Meditech Corporation Information
6.13.2 Golden Meditech Overview
6.13.3 Golden Meditech Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.13.4 Golden Meditech Regenerative Medicine Products Product Description
6.13.5 Golden Meditech Recent Developments
6.14 Cytori Therapeutics
6.14.1 Cytori Therapeutics Corporation Information
6.14.2 Cytori Therapeutics Overview
6.14.3 Cytori Therapeutics Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.14.4 Cytori Therapeutics Regenerative Medicine Products Product Description
6.14.5 Cytori Therapeutics Recent Developments
6.15 Celgene
6.15.1 Celgene Corporation Information
6.15.2 Celgene Overview
6.15.3 Celgene Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.15.4 Celgene Regenerative Medicine Products Product Description
6.15.5 Celgene Recent Developments
6.16 Vericel Corporation
6.16.1 Vericel Corporation Corporation Information
6.16.2 Vericel Corporation Overview
6.16.3 Vericel Corporation Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.16.4 Vericel Corporation Regenerative Medicine Products Product Description
6.16.5 Vericel Corporation Recent Developments
6.17 Guanhao Biotech
6.17.1 Guanhao Biotech Corporation Information
6.17.2 Guanhao Biotech Overview
6.17.3 Guanhao Biotech Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.17.4 Guanhao Biotech Regenerative Medicine Products Product Description
6.17.5 Guanhao Biotech Recent Developments
6.18 Mesoblast
6.18.1 Mesoblast Corporation Information
6.18.2 Mesoblast Overview
6.18.3 Mesoblast Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.18.4 Mesoblast Regenerative Medicine Products Product Description
6.18.5 Mesoblast Recent Developments
6.19 Stemcell Technologes
6.19.1 Stemcell Technologes Corporation Information
6.19.2 Stemcell Technologes Overview
6.19.3 Stemcell Technologes Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.19.4 Stemcell Technologes Regenerative Medicine Products Product Description
6.19.5 Stemcell Technologes Recent Developments
6.20 Bellicum Pharmaceuticals
6.20.1 Bellicum Pharmaceuticals Corporation Information
6.20.2 Bellicum Pharmaceuticals Overview
6.20.3 Bellicum Pharmaceuticals Regenerative Medicine Products Sales and Revenue in United States Market (2016-2021)
6.20.4 Bellicum Pharmaceuticals Regenerative Medicine Products Product Description
6.20.5 Bellicum Pharmaceuticals Recent Developments
7 United States Regenerative Medicine Products Production Capacity, Analysis
7.1 United States Regenerative Medicine Products Production Capacity, 2016-2027
7.2 Regenerative Medicine Products Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Regenerative Medicine Products Supply Chain Analysis
9.1 Regenerative Medicine Products Industry Value Chain
9.2 Regenerative Medicine Products Upstream Market
9.3 Regenerative Medicine Products Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Regenerative Medicine Products Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Regenerative Medicine Products in United States Market
Table 2. Top Regenerative Medicine Products Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Regenerative Medicine Products Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Regenerative Medicine Products Revenue Share by Companies, 2016-2021
Table 5. United States Regenerative Medicine Products Sales by Companies, (Units), 2016-2021
Table 6. United States Regenerative Medicine Products Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Regenerative Medicine Products Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers Regenerative Medicine Products Product Type
Table 9. List of Tier 1 Regenerative Medicine Products Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Regenerative Medicine Products Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Cell Therapy
Table 12. Major Manufacturers of Tissue Engineering
Table 13. By Type - United States Regenerative Medicine Products Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Regenerative Medicine Products Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Regenerative Medicine Products Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Regenerative Medicine Products Sales (Units), 2016-2021
Table 17. By Type - United States Regenerative Medicine Products Sales (Units), 2022-2027
Table 18. By Application - United States Regenerative Medicine Products Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Regenerative Medicine Products Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Regenerative Medicine Products Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Regenerative Medicine Products Sales (Units), 2016-2021
Table 22. By Application - United States Regenerative Medicine Products Sales (Units), 2022-2027
Table 23. Acelity Corporation Information
Table 24. Acelity Description and Major Businesses
Table 25. Acelity Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. Acelity Regenerative Medicine Products Product
Table 27. Acelity Recent Developments
Table 28. DePuy Synthes Corporation Information
Table 29. DePuy Synthes Description and Major Businesses
Table 30. DePuy Synthes Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. DePuy Synthes Regenerative Medicine Products Product
Table 32. DePuy Synthes Recent Developments
Table 33. Medtronic Corporation Information
Table 34. Medtronic Description and Major Businesses
Table 35. Medtronic Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. Medtronic Regenerative Medicine Products Product
Table 37. Medtronic Recent Developments
Table 38. ZimmerBiomet Corporation Information
Table 39. ZimmerBiomet Description and Major Businesses
Table 40. ZimmerBiomet Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. ZimmerBiomet Regenerative Medicine Products Product
Table 42. ZimmerBiomet Recent Developments
Table 43. Stryker Corporation Information
Table 44. Stryker Description and Major Businesses
Table 45. Stryker Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 46. Stryker Regenerative Medicine Products Product
Table 47. Stryker Recent Developments
Table 48. MiMedx Group Corporation Information
Table 49. MiMedx Group Description and Major Businesses
Table 50. MiMedx Group Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 51. MiMedx Group Regenerative Medicine Products Product
Table 52. MiMedx Group Recent Developments
Table 53. Organogenesis Corporation Information
Table 54. Organogenesis Description and Major Businesses
Table 55. Organogenesis Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 56. Organogenesis Regenerative Medicine Products Product
Table 57. Organogenesis Recent Developments
Table 58. UniQure Corporation Information
Table 59. UniQure Description and Major Businesses
Table 60. UniQure Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 61. UniQure Regenerative Medicine Products Product
Table 62. UniQure Recent Developments
Table 63. Cellular Dynamics International Corporation Information
Table 64. Cellular Dynamics International Description and Major Businesses
Table 65. Cellular Dynamics International Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 66. Cellular Dynamics International Regenerative Medicine Products Product
Table 67. Cellular Dynamics International Recent Developments
Table 68. Osiris Therapeutics Corporation Information
Table 69. Osiris Therapeutics Description and Major Businesses
Table 70. Osiris Therapeutics Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 71. Osiris Therapeutics Regenerative Medicine Products Product
Table 72. Osiris Therapeutics Recent Developments
Table 73. Vcanbio Corporation Information
Table 74. Vcanbio Description and Major Businesses
Table 75. Vcanbio Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 76. Vcanbio Regenerative Medicine Products Product
Table 77. Vcanbio Recent Developments
Table 78. Gamida Cell Corporation Information
Table 79. Gamida Cell Description and Major Businesses
Table 80. Gamida Cell Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 81. Gamida Cell Regenerative Medicine Products Product
Table 82. Gamida Cell Recent Developments
Table 83. Golden Meditech Corporation Information
Table 84. Golden Meditech Description and Major Businesses
Table 85. Golden Meditech Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 86. Golden Meditech Regenerative Medicine Products Product
Table 87. Golden Meditech Recent Developments
Table 88. Cytori Therapeutics Corporation Information
Table 89. Cytori Therapeutics Description and Major Businesses
Table 90. Cytori Therapeutics Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 91. Cytori Therapeutics Regenerative Medicine Products Product
Table 92. Cytori Therapeutics Recent Developments
Table 93. Celgene Corporation Information
Table 94. Celgene Description and Major Businesses
Table 95. Celgene Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 96. Celgene Regenerative Medicine Products Product
Table 97. Celgene Recent Developments
Table 98. Vericel Corporation Corporation Information
Table 99. Vericel Corporation Description and Major Businesses
Table 100. Vericel Corporation Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 101. Vericel Corporation Regenerative Medicine Products Product
Table 102. Vericel Corporation Recent Developments
Table 103. Guanhao Biotech Corporation Information
Table 104. Guanhao Biotech Description and Major Businesses
Table 105. Guanhao Biotech Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 106. Guanhao Biotech Regenerative Medicine Products Product
Table 107. Guanhao Biotech Recent Developments
Table 108. Mesoblast Corporation Information
Table 109. Mesoblast Description and Major Businesses
Table 110. Mesoblast Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 111. Mesoblast Regenerative Medicine Products Product
Table 112. Mesoblast Recent Developments
Table 113. Stemcell Technologes Corporation Information
Table 114. Stemcell Technologes Description and Major Businesses
Table 115. Stemcell Technologes Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 116. Stemcell Technologes Regenerative Medicine Products Product
Table 117. Stemcell Technologes Recent Developments
Table 118. Bellicum Pharmaceuticals Corporation Information
Table 119. Bellicum Pharmaceuticals Description and Major Businesses
Table 120. Bellicum Pharmaceuticals Regenerative Medicine Products Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 121. Bellicum Pharmaceuticals Regenerative Medicine Products Product
Table 122. Bellicum Pharmaceuticals Recent Developments
Table 123. Regenerative Medicine Products Production Capacity (Units) of Key Manufacturers in United States Market, 2019-2021 (Units)
Table 124. United States Regenerative Medicine Products Capacity Market Share of Key Manufacturers, 2019-2021
Table 125. Regenerative Medicine Products Market Opportunities & Trends in United States Market
Table 126. Regenerative Medicine Products Market Drivers in United States Market
Table 127. Regenerative Medicine Products Market Restraints in United States Market
Table 128. Regenerative Medicine Products Raw Materials
Table 129. Regenerative Medicine Products Raw Materials Suppliers in United States Market
Table 130. Typical Regenerative Medicine Products Downstream
Table 131. Regenerative Medicine Products Downstream Clients in United States Market
Table 132. Regenerative Medicine Products Distributors and Sales Agents in United States Market
List of FiguresFigure 1. Regenerative Medicine Products Product Picture
Figure 2. Regenerative Medicine Products Segment by Type
Figure 3. Regenerative Medicine Products Segment by Application
Figure 4. United States Regenerative Medicine Products Market Overview: 2020
Figure 5. United States Regenerative Medicine Products Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Regenerative Medicine Products Revenue, 2016-2027 (US$, Mn)
Figure 7. Regenerative Medicine Products Sales in United States Market: 2016-2027 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Regenerative Medicine Products Revenue in 2020
Figure 9. Cell Therapy Product Picture
Figure 10. Tissue Engineering Product Picture
Figure 11. Biomaterial Product Picture
Figure 12. Others Product Picture
Figure 13. By Type - United States Regenerative Medicine Products Sales Market Share, 2016-2027
Figure 14. By Type - United States Regenerative Medicine Products Revenue Market Share, 2016-2027
Figure 15. By Type - United States Regenerative Medicine Products Price (USD/Unit), 2016-2027
Figure 16. Dermatology
Figure 17. Cardiovascular
Figure 18. CNS
Figure 19. Orthopedic
Figure 20. Others
Figure 21. By Application - United States Regenerative Medicine Products Sales Market Share, 2016-2027
Figure 22. By Application - United States Regenerative Medicine Products Revenue Market Share, 2016-2027
Figure 23. By Application - United States Regenerative Medicine Products Price (USD/Unit), 2016-2027
Figure 24. Acelity Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. DePuy Synthes Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Medtronic Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. ZimmerBiomet Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Stryker Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. MiMedx Group Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Organogenesis Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. UniQure Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Cellular Dynamics International Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Osiris Therapeutics Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. Vcanbio Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. Gamida Cell Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 36. Golden Meditech Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 37. Cytori Therapeutics Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Celgene Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Vericel Corporation Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Guanhao Biotech Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Mesoblast Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Stemcell Technologes Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Bellicum Pharmaceuticals Regenerative Medicine Products Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. United States Regenerative Medicine Products Production Capacity (Units), 2016-2027
Figure 45. Regenerative Medicine Products Industry Value Chain
Figure 46. Marketing Channels